formamides - CISMeF

Preferred Label : formamides;

MeSH definition : A group of amides with the general formula of R-CONH2.;

MeSH annotation : D25-26 qualif;

Is substance : O;

Details

Origin ID

D005559;

UMLS CUI

C0016569;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- analysis [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Formamide (substance) [SNOMED CT concept]
- formamide [Substance BNPC]
- formamide [SNOMED Notion]
Record concept(s)
- formamides [MeSH concept]
Related MeSH Supplementary Concept(s)
- (5RS,6SR)-6-(4-fluorobenzoyl)-5-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5,6-dihydro-4H-1,3,4-oxadiazine N,N-dimethylformamide [MeSH Supplementary Concept]
- (8RS)-4-amino-6-(4-chlorophenyl)-8-(2,4-dichlorothiazol-5-yl)-8,9-dihydro-7H-pyrimido(4,5-b)(1,4)diazepine N,N-dimethylformamide [MeSH Supplementary Concept]
- 1-(1H-Indol-3-ylcarbonyl)-N-(4-methoxybenzyl)formamide [MeSH Supplementary Concept]
- 1-(tert-butoxyformamido)-2,2-dibromo-1-phenyl-2-nitroethane [MeSH Supplementary Concept]
- 1-aminomethanamide [MeSH Supplementary Concept]
- 2,4-dimethylformanilide [MeSH Supplementary Concept]
- 2-amino-5-(3,4-dimethoxybenzylidene)-1-methylimidazol-4(5H)-one N,N-dimethylformamide [MeSH Supplementary Concept]
- 2-pyridineformamide [MeSH Supplementary Concept]
- 3,5-diamino-6-(2-fluorophenyl)-1,2,4-triazine-dimethylformamide [MeSH Supplementary Concept]
- 4-chloroformanilide [MeSH Supplementary Concept]
- 4-nitroformanilide [MeSH Supplementary Concept]
- 5-(formyl-(3-(formyl-(3,5-bis (2,3-dihydroxypropylcarbamoyl)-2,4,6-triiodophenyl) amino)-2-hydroxypropyl)amino)-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodobenzene-1,3-dicarboxamide [MeSH Supplementary Concept]
- H 95-71 [MeSH Supplementary Concept]
- N,N'-((1Z,3Z)-1,4-bis(4-methoxyphenyl)buta-1,3-diene-2,3-diyl)diformamide [MeSH Supplementary Concept]
- N,N'-di(p-thiazole)formamidine [MeSH Supplementary Concept]
- N,N-dimethylformamide disolvate [MeSH Supplementary Concept]
- N,N-dimethylformimidamide [MeSH Supplementary Concept]
- N-((2E,6E,10E)-3,7,11,15-tetramethyl-13-oxohexadeca-2,6,10-trien-1-yl)formamide [MeSH Supplementary Concept]
- N-(1-(2,2-dimethyl-1,3-dioxol-4-yl)-2-((4,4-(trifluoromethoxyphenoxy)phenyl)sulfonyl)ethyl)-N-hydroxyformamide [MeSH Supplementary Concept]
- N-(1-methyl-3,3-diphenylpropyl)formamide [MeSH Supplementary Concept]
- N-(2,6-dichloro-4-(2-oxiacetyl)phenylformamide) [MeSH Supplementary Concept]
- N-(2,6-difluorophenyl)formamide [MeSH Supplementary Concept]
- N-(2-amino-6-((2-deoxy-beta-D-erythro-pentofuranosyl)amino)-3,4-dihydro-4-oxo-5-pyrimidinyl)-N-(2-oxoethyl)-formamide [MeSH Supplementary Concept]
- N-(2-cis(4-hydroxyphenyl)ethenyl)formamide [MeSH Supplementary Concept]
- N-(2-deoxypentofuranosyl)formamide [MeSH Supplementary Concept]
- N-(3-chloro-4-morpholin-4-yl) phenyl-N'-hydroxyimido formamide [MeSH Supplementary Concept]
- N-(4,5-dihydro-5-oxo-1,2-dithiolo(4,3-b)pyrrol-6-yl)-N-methylformamide [MeSH Supplementary Concept]
- N-(4-butoxybenzyl)formamide [MeSH Supplementary Concept]
- N-benzylformamide [MeSH Supplementary Concept]
- N-cyclohexylformamide [MeSH Supplementary Concept]
- N-cyclopropylformamide [MeSH Supplementary Concept]
- N-ethylformamide [MeSH Supplementary Concept]
- N-formylformimidic acid [MeSH Supplementary Concept]
- N-furfurylformamide [MeSH Supplementary Concept]
- N-hydroxymethylformamide [MeSH Supplementary Concept]
- N-phenylformamide [MeSH Supplementary Concept]
- N-ribofuranosylformamide 5'-phosphate [MeSH Supplementary Concept]
- N4-(2-deoxypentofuranosyl)-4,6-diamino-5-formamidopyrimidine [MeSH Supplementary Concept]
- N6-(2-deoxy-erythro-pentofuranosyl)-2,6-diamino-4-hydroxy-5-formamidopyrimidine [MeSH Supplementary Concept]
- OMDM 169 [MeSH Supplementary Concept]
- VMI 160 [MeSH Supplementary Concept]
- VS55 solution [MeSH Supplementary Concept]
- ceratinamine [MeSH Supplementary Concept]
- di-(1-phenylisopropyl)formamide [MeSH Supplementary Concept]
- diphenylformamide [MeSH Supplementary Concept]
- formamide [MeSH Supplementary Concept]
- fumiformamide [MeSH Supplementary Concept]
- melanocin C [MeSH Supplementary Concept]
- methyl 2-(formamido)acrylate [MeSH Supplementary Concept]
- methyl 2-(formamido)cinnamate [MeSH Supplementary Concept]
- methylformamide [MeSH Supplementary Concept]
- poly((5-carboxybutyl formamide)-2-acetyl salicylic anhydride) [MeSH Supplementary Concept]
- poly(vinyl formamide-co-vinyl amine) [MeSH Supplementary Concept]
- rhodium(II)(N,N'-di-4-tolylformidinate)(trifluoroacetato) [MeSH Supplementary Concept]
- thioformamide [MeSH Supplementary Concept]
- trans-N-vinylformamide [MeSH Supplementary Concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients